110 filings
Page 2 of 6
8-K
97t1wmc76f3sdql 6j
21 Apr 23
Gamida Cell Announces Launch of Public Offering of Securities
7:19am
8-K
m122ttxn1if zg
17 Apr 23
Gamida Cell’s Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval
5:29pm
8-K
cbgtc8
27 Mar 23
Gamida Cell Reports Full Year 2022 Financial Results and Provides Company Update
7:15am
8-K
m1wm86md
20 Mar 23
Gamida Cell Announces Changes to Board of Directors
4:45pm
8-K
10376 gm0qeo27
30 Jan 23
Other Events
7:00am
8-K
9lzzoshgow 044tvfqr
19 Jan 23
Other Events
4:43pm
8-K
a4wiqnne
9 Jan 23
Regulation FD Disclosure
12:15pm
8-K
y8kp6 t5rni
12 Dec 22
Gamida Cell Announces Closing of $25 Million Financing with Highbridge
7:15am
8-K
78nal1 w69z3777nsk
21 Nov 22
Gamida Cell Provides Regulatory Update on Omidubicel
5:20pm
8-K
2nyvi
14 Nov 22
Gamida Cell Reports Third Quarter 2022 Financial Results
7:15am
8-K
h153a zb2xwpk
30 Sep 22
Gamida Cell Announces Pricing of Approximately $20 Million Public Offering of Ordinary Shares
4:02pm
8-K
3momd wgtrqr53fm8
27 Sep 22
Gamida Cell Announces Launch of Public Offering of Ordinary Shares
5:03pm
8-K
vgow5
19 Sep 22
Departure of Directors or Certain Officers
7:06am
8-K
twwbuu 9xqmecd
15 Aug 22
Gamida Cell Reports Second Quarter 2022 Financial Results
7:15am
8-K
mqv1n acg87xpqe946uy
10 Aug 22
Gamida Cell Announces Dosing of First Patient in Company-Sponsored Phase
12:00am
8-K
pyjjpdh r1v
1 Aug 22
Gamida Cell Announces FDA Acceptance of
7:30am
8-K
du3d4h
29 Jul 22
Departure of Directors or Certain Officers
4:58pm
8-K
fpexw
10 Jun 22
Departure of Directors or Certain Officers
7:30am
8-K
al48zbn
2 Jun 22
Gamida Cell Completes
7:31am
8-K
v00vww8c6imor
10 May 22
Gamida Cell Reports First Quarter 2022 Financial Results
7:30am